Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Reports surrounding the analysis of tonsillar and appendix
tissue for evidence of variant Creutzfeldt-Jakob disease (vCJD)1 have highlighted the difficulty faced by
scientists in presenting complex and emotive medical information to the
public. Great care is needed, especially when the implications of
results are uncertain.
The discovery of prion protein in an appendix removed from a patient in Torbay in 1995 before the onset of clinical signs of new variant Creutzfeldt-Jakob disease (nvCJD) raised the possibility of diagnosing cases before patients are aware that they are infected. A programme of testing several thousand pathological specimens of appendixes and tonsils was started. The intention was to test whether nvCJD prion protein might be present in any of them and, if it was, to assess its significance.2
Preliminary results from this study were recently released to the
press. No cases were found in any of the 3000 samples of tonsil and
appendix